ArticleHemaSphere2026

SLV-404, an anti-RYK antibody-drug conjugate, is effective in Richter transformation patient-derived xenografts.

Matilde Micillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.